2020-07-14T21:32:36-05:00 2019-06-30 814234542 BPM LLP 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 940251021 990 2018-07-01 453266802 CANCER COMMONS CANC 6505303636 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 JAY M TENENBAUM PRESIDENT, CHAIRMAN, AND DIRECTOR 6505303636 2020-07-08 1 TAMARA L MCINERNEY P00011797 6508556800 2020-07-08 208.184.139.130 2020-07-08 17:54:13 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 98C12E8E5E1AA7A5910964E34E069994ED632D96 2018 2021-01-29 14:40:06Z JAY M TENENBAUM 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 1805146 0 X WWW.CANCERCOMMONS.ORG X 2011 CA CANCER COMMONS, BY DESIGN, IS A NEUTRAL, PATIENT-CENTRIC NON-PROFIT CLEARINGHOUSE THAT ENCOURAGES KNOWLEDGE AND DATA SHARING BY INDIVIDUAL PATIENTS AND PHYSICIANS AS WELL AS NON-PROFIT, COMMERCIAL, AND GOVERNMENT ENTITIES. WE USE INFORMATION TECHNOLOGY, ARTIFICIAL INTELLIGENCE (AI), AND CROWDSOURCING TO HELP PATIENTS AND PHYSICIANS MAKE THE BEST POSSIBLE DECISIONS, AND CONTINUALLY LEARN FROM EACH PATIENT'S RESULTS. 7 6 11 4 0 0 1622936 1802646 138869 0 0 0 5196 2500 1767001 1805146 0 0 0 0 829588 786496 150069 19000 164798 917832 544267 1897489 1349763 -130488 455383 296303 775135 216793 240242 79510 534893 X CANCER COMMONS AIMS TO ENSURE THAT PATIENTS AND THEIR PHYSICIANS HAVE THE KNOWLEDGE THEY NEED TO MAKE THE BEST POSSIBLE PERSONALIZED TREATMENT DECISIONS, AND TO CONTINUOUSLY UPDATE THAT KNOWLEDGE BASED ON EACH PATIENT'S RESPONSE. 0 0 478527 PATIENT SERVICES: ALL CANCERS (EXCEPT BRAIN & PANCREATIC) KNOWLEDGEABLE SCIENTISTS AND EXPERT PHYSICIANS PROVIDE CANCER PATIENTS WITH EDUCATION AND INFORMATION TO HELP THEM NAVIGATE CANCER TREATMENT. PATIENTS RECEIVE PERSONALIZED SERVICES THAT MAY INCLUDE CASE-SPECIFIC RESOURCES AND INFORMATION, INDIVIDUALIZED TREATMENT OPTIONS, AND SUPPORT IN ACCESSING THOSE OPTIONS. PATIENT PROGRESS IS TRACKED TO PROVIDE MID-COURSE CORRECTIONS AND IMPROVE SERVICES FOR FUTURE PATIENTS. ACCOMPLISHMENTS:THIS YEAR, OUR WEB-BASED PATIENT SERVICE RESPONDED TO INQUIRIES FROM NEARLY 1,000 NEW PATIENTS. OVER 80% OF PATIENTS WERE MATCHED WITH RELEVANT CLINICAL TRIALS, AND 70% ENGAGED THROUGHOUT THEIR CANCER JOURNEY. OVER THE PAST DECADE, WE HAVE HAD CLOSE TO 25,000 INTERACTIONS WITH OVER 4000 PATIENTS AND THEIR CAREGIVERS, IN 69 COUNTRIES. 119529 PATIENT SERVICES: PANCREATIC CANCER PROGRAM: NOVEL TREATMENT OPTIONS FOR ADVANCED PANCREATIC CANCER PATIENTS PATIENT CASES ARE VETTED THROUGH VIRTUAL TUMOR BOARDS. THE VIRTUAL TUMOR BOARDS ARE COMPRISED OF INTERNAL PHD STAFF SCIENTISTS, AUGMENTED BY A NETWORK OF NATIONALLY-RECOGNIZED PANCREATIC CANCER EXPERTS INCLUDING ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS, AND CLINICAL SCIENTISTS. THESE EXPERTS PROVIDE FEEDBACK ON CURRENT TREATMENT PLANS, AND RATIONALES FOR CONSIDERING NOVEL TESTING AND TREATMENT OPTIONS THROUGH A COLLECTIVE REASONING PROCESS. PATIENTS ARE PROVIDED WITH A COMPREHENSIVE REPORT TO DISCUSS WITH THEIR TREATING PHYSICIAN. PATIENTS ARE THEN CONTINUOUSLY MONITORED TO LEARN WHAT THEY DID AND HOW WELL IT IS WORKING. ADDITIONALLY, CANCER COMMONS HELPS FACILITATE ACCESS TO INVESTIGATIONAL AND OFF-LABEL THERAPIES, THROUGH EXPANDED ACCESS PROGRAMS AND REIMBURSEMENT SUPPORT. ACCOMPLISHMENTS: DURING FISCAL YEAR 19 27 PANCREATIC CANCER PATIENTS PARTICIPATED IN THIS PROGRAM. 343277 PATIENT SERVICES: BRAIN CANCER PROGRAM: NOVEL TREATMENT OPTIONS FOR ADVANCED BRAIN CANCER PATIENTS PATIENT CASES ARE VETTED THROUGH VIRTUAL TUMOR BOARDS. THE VIRTUAL TUMOR BOARDS ARE COMPRISED OF INTERNAL PHD STAFF SCIENTISTS, AUGMENTED BY A NETWORK OF NATIONALLY-RECOGNIZED BRAIN CANCER EXPERTS INCLUDING ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS, AND CLINICAL SCIENTISTS. THESE EXPERTS PROVIDE FEEDBACK ON CURRENT TREATMENT PLANS, AND RATIONALES FOR CONSIDERING NOVEL TESTING AND TREATMENT OPTIONS THROUGH A COLLECTIVE REASONING PROCESS. PATIENTS ARE PROVIDED WITH A COMPREHENSIVE REPORT TO DISCUSS WITH THEIR TREATING PHYSICIAN. PATIENTS ARE THEN CONTINUOUSLY MONITORED TO LEARN WHAT THEY DID AND HOW WELL IT IS WORKING. ADDITIONALLY, CANCER COMMONS HELPS FACILITATE ACCESS TO INVESTIGATIONAL AND OFF-LABEL THERAPIES, THROUGH EXPANDED ACCESS PROGRAMS AND REIMBURSEMENT SUPPORT. ACCOMPLISHMENTS: DURING FISCAL YEAR 19 127 BRAIN PATIENTS PARTICIPATED IN THIS PROGRAM. 93506 PATIENT SERVICES: PLATFORM DEVELOPMENT 93506 1034839 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 19 0 11 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X MARTHA DEHNOW 6505303636 650 CASTRO STREET SUITE 120 PMB522 MOUNTAIN VIEW CA 94041 AJIT SINGH DIRECTOR 1.00 X 0 0 0 DICK LEVY DIRECTOR 2.00 X 0 0 0 EDWARD STAREN DIRECTOR 1.00 X 0 0 0 GLADYS MONROY DIRECTOR 2.00 X 0 0 0 HEATHER RANGEL DIRECTOR 1.00 X 0 0 0 JAY M TENENBAUM CHAIR, DIRECTOR, PRESIDENT 20.00 X X 0 0 1473 LAURENCE MARTON DIRECTOR 2.00 X 0 0 0 SHELLEY FRISBIE CFO 1.00 X 0 0 0 FRANK MCCORMICK THROUGH 53119 DIRECTOR 1.00 X 0 0 0 ERIKA MONTEVERDI EXECUTIVE DIRECTOR 30.00 X 172576 0 22336 MARTHA DEHNOW THROUGH 103118 CFO 30.00 X 42790 0 36780 MASAKO YOKOTA SECRETARY 40.00 X 86978 0 14523 EMILYA SHTIVELMAN CHIEF SCIENTIST 33.00 X 129000 0 19047 431344 0 94159 2 0 1 0 0 1802646 250 1802646 MISCELLANEOUS INCOME 900099 2500 2500 2500 1805146 0 0 2500 X 290314 161675 70828 57811 417174 405107 3017 9050 29578 23142 1609 4827 49430 40976 3409 5045 5753 5753 9625 9625 19000 19000 153691 118507 1884 33300 158342 134589 23402 351 19337 14463 4874 96911 78282 6149 12480 50533 29717 14873 5943 27094 22388 1542 3164 13641 5341 8300 264 264 316 316 7135 7135 SPECIAL EVENT 653 653 RECRUITING 552 552 TAXES AND LICENSES 245 245 MISC 100 100 75 75 1349763 1034839 150126 164798 89042 557450 189164 155000 0 30554 11185 19265 7416 3462 0 3954 0 2000 6912 6912 296303 775135 198793 108581 18000 131661 216793 240242 X -27996 14432 107506 520461 79510 534893 296303 775135 455383 0 X 0 0 0 X 1352290 810884 1410505 1622936 1802396 6999011 1352290 810884 1410505 1622936 1802396 6999011 4117934 2881077 2500 2500 7001511 0.41150 0.44240 X PART II, SECTION C, LINE 14: PUBLIC SUPPORT PERCENTAGE FOR 2017 WAS RESTATED. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 7416 3462 3954 3954 ACCRUED LIABILITIES 6750 XCURES STOCK ADJUSTMENT 124911 131661 X X X X 1 THERESE QUINLAN 1529 SEAPORT BLVD REDWOOD CITY CA 94063 IN CHARGE OF STRATEGY, ADVISE/STRATEGIZE 0 0 19000 -19000 19000 -19000 CA X 0 0 0 0 0 0 0 0 0 ERIKA MONTEVERDI EXECUTIVE DIRECTOR 172576 0 0 0 0 0 0 0 22336 0 194912 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS GIVEN TO THE GOVERNING BODY BEFORE THE RETURN IS FILED. THEY REVIEW AND CAN REQUEST CHANGES AT THIS TIME. FORM 990, PART VI, SECTION B, LINE 12C THE OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO REVIEW AND SIGN THE WRITTEN CONFLICT OF INTEREST POLICY ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 THE GOVERNANCE COMMITTEE PERFORMS ALL INTERVIEWS SPECIFIC TO TOP KEY POSITIONS WHICH IS THEN FORWARDED TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PAYROLL SERVICES RELATED: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 1,884. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,884. OUTSIDE CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 118,507. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 118,507. DEVELOPMENT DEPARTMENT ASSISTANTS: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 33,300. TOTAL EXPENSES 33,300.